Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032
Overview
The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is expected to reach a 463.65 USD Million by 2032 and is projected to grow at a CAGR of 6.64% from 2025 to 2032.
Revenue, 2024 (USD Million)
295.63
Forecast, 2032 (USD Million)
463.65
CAGR, 2024 - 2032
6.64%
Report Coverage
Asia-Pacific
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market 2018-2032 USD Million
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 295.63 USD Million
- Projected Market Size (2032): 463.65 USD Million
- CAGR (2025-2032): 6.64%
Key Findings of Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market
- The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market was valued at 295.63 USD Million in 2024.
- The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is likely to grow at a CAGR of 6.64% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment End User in Prescription Segment accounted for the largest share of the market with a revenue of 295.63 USD Million
- The fastest growing segment Amphetamines in Drug Type Segment grew Fastest with a CAGR of 8.48% during the forecast period from 2024 to 2032.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Scope
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Segmentation & Scope
Prescription
- Prescription-Based Testing
- Over the Counter Testing
- End User
- Sample Type
- Application
- Testing Type
Products
- Consumables and Accessories
- Devices
Drug Type
- Others
- Tricyclic Antidepressants
- Phencyclidine
- Methadone
- Benzodiazepines
- Barbiturates
- Cocaine
- Cannabinoids
- Opiates
- Amphetamines
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 295.63 USD Million |
| Market Value in 2032 | 463.65 USD Million |
| CAGR (2025-2032) | 6.64% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Prescription,Products,Drug Type,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 295.63 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 75.11 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Prescription
- End User is the largest segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 295.63 USD Million in the year 2024.
- Over the Counter Testing is the Fastest growing segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 6.64 % in forecast period 2025-2032.
-
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Products
- Devices is the largest segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 198.73 USD Million in the year 2024.
- Consumables and Accessories is the Fastest growing segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 6.46 % in forecast period 2025-2032.
-
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Drug Type
- Amphetamines is the largest segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 81.88 USD Million in the year 2024.
- Amphetamines is the Fastest growing segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 8.48 % in forecast period 2025-2032.
-
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a revenue of 187.13 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market to 2032 with a Growth rate of 6.73 % in forecast period 2025-2032.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Prescription,Products,Drug Type,Distribution Channel.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 295.63(Revenue in USD Million) in 2023.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 6.64% during the forecast period of 2024 to 2032.
The End User segment is expected to dominate the Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market, holding a largest market share of 295.63 USD Million in 2024
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Scope
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Segmentation & Scope
Prescription
- Prescription-Based Testing
- Over the Counter Testing
- End User
- Sample Type
- Application
- Testing Type
Products
- Consumables and Accessories
- Devices
Drug Type
- Others
- Tricyclic Antidepressants
- Phencyclidine
- Methadone
- Benzodiazepines
- Barbiturates
- Cocaine
- Cannabinoids
- Opiates
- Amphetamines
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Prescription,Products,Drug Type,Distribution Channel.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 295.63(Revenue in USD Million) in 2023.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 6.64% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market for final year is USD 463.65 (USD Million).
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is segmented based on Segmentation Prescription,Products,Drug Type,Distribution Channel.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market was valued at USD 295.63(Revenue in USD Million) in 2023.
Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market is projected to grow at a CAGR of 6.64% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Point-of-Care (POC) Drug Abuse Testing Market for final year is USD 463.65 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.